Manning Meredith's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Mar 31, 2026
- Accession no.
- 0001752631-26-000002
- Filed
- Mar 31, 2026
- Trade date
- Mar 27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $229.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning MeredithCIK 0001752631 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Common Stock | SSaleDisposed | −4,864 | $30.04 | −$146,114.56 | 67,165 | Direct | |
| Mar 27, 2026 | Common Stock | SSaleDisposed | −2,100 | $31.04 | −$65,184 | 65,065 | Direct | |
| Mar 27, 2026 | Common Stock | SSaleDisposed | −558 | $31.72 | −$17,699.76 | 64,507 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.